Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Clasificación en acciones #18727
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Precio por acción
$2.35
Capitalización bursátil
$4.22M
Cambio (1 día)
-5.69%
Cambio (1 año)
838.98%
País
MY
Comercio BioNexus Gene Lab Corporation (BGLC)

Categoría

Ganancias de BioNexus Gene Lab Corporation (BGLC)
Ganancias en Sep 2025 TTM: $-2.37M
Secondo gli ultimi rapporti finanziari di BioNexus Gene Lab Corporation, gli utili attuali della società sono $-2.37M. Nel 2023, la società ha registrato un utile di $-2.61M, una disminución en comparación con agli utili del 2022, che erano di $-303.66K. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de BioNexus Gene Lab Corporation desde 2016 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-2.37M 48.64%
2024 $-1.59M -38.84%
2023 $-2.61M 758.71%
2022 $-303.66K -129.12%
2021 $1.04M -17.40%
2020 $1.26M -557.92%
2019 $-275.71K -560.27%
2018 $59.90K -150.16%
2017 $-119.41K 14,201.08%
2016 $-835.00 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.27B -306,699.14%
US
$4.23B -178,668.26%
US
$1.32B -55,960.65%
US
$2.63B -111,037.93%
CN
$1.43B -60,508.64%
US